Revised Geneva Score Calculator for Pulmonary Embolism

Score the eight clinical Revised Geneva criteria - age, prior VTE, recent surgery or fracture, active cancer, leg findings, hemoptysis, and heart rate - to estimate the clinical pretest probability of pulmonary embolism.

Quick Facts

Score range
0 to 22 points
Eight clinical variables, weighted per the original Le Gal et al. 2006 point system.
Three-level cutoffs
Low 0-3, Intermediate 4-10, High 11+
Higher scores indicate higher pretest probability of PE.
Two-level cutoff
PE unlikely 0-5, PE likely 6+
Dichotomized version often paired with D-dimer testing pathways.

Your Results

Calculated
Revised Geneva Score
-
Total points (0-22)
Clinical probability
-
3-tier: low / intermediate / high
Dichotomized category
-
2-tier: PE unlikely / PE likely (cutoff 6)
Est. PE prevalence
-
Derivation cohort band (Le Gal 2006)

Ready

Enter the eight clinical findings, then calculate the Revised Geneva Score.

About the Revised Geneva Score

The Revised Geneva Score is a fully objective clinical decision rule for estimating the pretest probability of acute pulmonary embolism (PE). Published by Le Gal and colleagues in 2006, it was designed to remove the subjective "gestalt" component of the original Geneva score, using only findings a clinician can obtain from the history, a brief exam, and vital signs. The score is typically used alongside a validated D-dimer strategy (for example the PERC rule, YEARS algorithm, or Wells score context) to decide who needs CT pulmonary angiography.

How the score is built

Eight clinical variables are each assigned a fixed number of points, and the points are summed:

  • Age over 65 years: 1 point.
  • Previous DVT or PE: 3 points.
  • Surgery (under general anesthesia) or lower-limb fracture within the past month: 2 points.
  • Active malignancy (solid or hematologic, currently active or considered cured less than 1 year ago): 2 points.
  • Unilateral lower-limb pain: 3 points.
  • Hemoptysis: 2 points.
  • Heart rate: 3 points for 75-94 beats/min, 5 points for 95 beats/min or higher, 0 points below 75.
  • Pain on lower-limb deep venous palpation combined with unilateral edema: 4 points.

The total ranges from 0 to 22 points. There is no adjustment for age beyond the single age-over-65 point, and no laboratory values are required.

Interpreting the score

The original publication reports two ways to group the total:

  • Three-level clinical probability: low (0-3 points), intermediate (4-10 points), high (11 points or more).
  • Two-level ("dichotomized") probability: PE unlikely (0-5 points), PE likely (6 points or more) - the format most often paired with a D-dimer cutoff to decide who can safely skip imaging.

In the derivation and validation cohorts, observed PE prevalence rose steeply across these bands - roughly 8% in the low-probability group, about 29% in the intermediate group, and about 74% in the high-probability group. These are cohort-level frequencies from the published study, not a probability calculated for any individual patient, and prevalence can differ in other populations.

When to consult a professional

This tool performs the standard Revised Geneva arithmetic for education and documentation. It does not diagnose PE, order imaging, or replace clinical judgment. Any decision about D-dimer testing, imaging, or anticoagulation should be made by the treating clinician using the full clinical picture.

Frequently Asked Questions

What is the Revised Geneva Score?
The Revised Geneva Score is a fully objective clinical prediction rule (Le Gal et al., 2006) that estimates the pretest probability of acute pulmonary embolism from eight findings available at the bedside - age, prior VTE, recent surgery or fracture, active cancer, unilateral leg pain, hemoptysis, heart rate, and leg exam findings. It removes the subjective clinical-judgment component used in the original Geneva score.
How is the Revised Geneva Score calculated?
Each of the eight variables adds fixed points: age over 65 (1), previous DVT or PE (3), surgery or lower-limb fracture within a month (2), active malignancy (2), unilateral lower-limb pain (3), hemoptysis (2), heart rate 75-94 (3) or 95+ (5), and pain on deep venous palpation with unilateral edema (4). Adding all applicable points gives a total from 0 to 22.
What do the score categories mean?
The total can be read two ways. The three-level scale groups 0-3 points as low probability, 4-10 as intermediate, and 11 or more as high probability. The two-level scale groups 0-5 as "PE unlikely" and 6 or more as "PE likely," which is commonly combined with a D-dimer test to decide whether imaging is needed. In the original validation study, PE prevalence was about 8% in the low group, 29% in the intermediate group, and 74% in the high group - population frequencies, not an individual patient's probability.

Related calculators